KBC Group’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,753
Closed -$49K 1806
2025
Q1
$49K Sell
2,753
-93,832
-97% -$1.88M ﹤0.01% 1793
2024
Q4
$2.35M Buy
96,585
+94,920
+5,701% +$2.71M 0.01% 672
2024
Q3
$62K Hold
1,665
﹤0.01% 1615
2024
Q2
$79K Buy
+1,665
New +$73K ﹤0.01% 1320

Other funds holding STAA

KBC Group's STAA Position: Q2 2025 in Review

KBC Group sold out of STAAR Surgical (STAA) in Q2 2025, closing a stake of 2,753 shares — an estimated $49K sold.

KBC Group first reported a position in STAA in Q2 2024 and held it in 4 quarters. The position peaked at $2.35M in Q4 2024. 170 funds tracked by Wall St. Rank hold STAA as of Q2 2025.

  • KBC Group reported no remaining STAAR Surgical position as of Q2 2025 after selling out during the quarter.
  • KBC Group sold 2,753 STAAR Surgical shares in Q2 2025, an estimated $49K.
  • KBC Group first reported a position in STAAR Surgical in Q2 2024 and held it in 4 quarters.
  • KBC Group's STAAR Surgical position peaked at $2.35M in Q4 2024.
  • 170 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2025.

Based on KBC Group's 13F filing for Q2 2025, filed 8 Aug 2025.